Chokri Ben Lamine: A Two-Day Journey Through Modern Hematology at KFSHRC
Chokri Ben Lamine, Hematologist at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn:
”Advancing Hematology Through Shared Expertise | KFSHRC Center of Excellence Clinical Hematology Meeting
King Faisal Specialist Hospital and Research Centre, Riyadh
KACOLD, Level 1 — Executive Meeting Room
30 September–1 October 2026
The KFSHRC Center of Excellence in CLL preceptorship brings together a comprehensive two-day program covering CLL, leukemia, lymphoma, myeloma and cellular therapy—with practical discussions connecting clinical evidence to everyday patient care.
Opening sessions
Feras Alfraih delivers the welcome address, followed by Hazzaa Alzahrani’s overview of KFSHRC and the Cancer Centre of Excellence.
Day 1 | CLL and Leukemia
Infection prevention, vaccination and antimicrobial prophylaxis in the era of novel agents — Maha Alamri
CLL diagnosis and prognostic markers — Mohamed Masoud
Treatment-naïve CLL — Omar Albanyan
Relapsed/refractory CLL and subsequent treatment lines — Marwan Shaheen
CLL case discussions and real-world challenges — Naeem Chaudhri
Future directions in CLL management, including ASH/EHA developments — Mansour Alfayez
Clinical vignettes in mantle cell lymphoma — Waleed Rasheed
How I treat ALL in 2026 — Amr Hanbali
Day 2 | Lymphoma, Myeloma and Cellular Therapy
Antibody–drug conjugates, T-cell engagers and CAR-T in ALL — Hanan Alkhaldi
DLBCL diagnosis and prognostic markers — Dr. Khalid Alghamdi
How I treat DLBCL in 2026 — Alfadel Alshaibani
Richter transformation — Ahmed Alnughmush
T-cell engagers versus CAR-T in DLBCL — Abdulwahab Albabtain
CAR-T clinical evidence and the KFSHRC experience — Syed Osman
Recognizing and managing CLL drug toxicities — Hadeel Samarkandi
The clinical research model at KFSHRC — Riad Elfakih
Multiple myeloma: novel agents and the role of CAR-T — Abdullah Alamer
Beyond the lectures, the program includes a hospital tour spanning clinical care, research, pathology, data services and innovation, alongside networking and interactive discussion.
An opportunity to exchange experience, discuss challenging cases and strengthen collaboration in hematologic cancer care.
Appreciation to the organizers and faculty for sharing their expertise.”
Other posts featuring Chokri Ben Lamine on Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC